ImmuneSpec
0797.707.610 · rovalta.com · 23/09/2026
ImmuneSpec
Overview
What does ImmuneSpec do?
ImmuneSpec is a Private limited company incorporated in 2023. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Niel. It employs on average 5,7 ETP workers (FTE).
2845 Niel · FlandreSee on map
Joint committees (4)
- 116
- 1160
- 207
- 2070
Trend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 883,6 k € | +26.8% | 696,9 k € | +1252% | 51,5 k € |
| EBITDA | 506,4 k € | +3.3% | 490,1 k € | +1796% | -28,9 k € |
| Operating result | -177,7 k € | -283% | -46,4 k € | +87.6% | -373 k € |
| Net result | -201,7 k € | -159% | -77,9 k € | +80.4% | -397,1 k € |
| Balance sheet | |||||
| Equity | 2,6 M € | +12.7% | 2,3 M € | +22.0% | 1,9 M € |
| Total assets | 3,5 M € | +11.2% | 3,2 M € | -0.9% | 3,2 M € |
| Cash | 191,9 k € | +69.3% | 113,3 k € | -52.5% | 238,7 k € |
| Debts | 829 k € | +9.2% | 759,4 k € | -18.1% | 927,6 k € |
| Other | |||||
| Workforce | 5,7 ETP | +67.6% | 3,4 ETP | +100% | 1,7 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 4 active · 7 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Administratiekantoor iFlux● Active | 0727.509.106 |
iFLUX● Active | 0683.854.156 |
Leonhard● Active | 0797.304.762 |
MENDES● Active | 0797.303.673 |
NIEUWE MEDIA GROEP● Active | 0454.028.888 |
PM GROUP BELGIUM● Active | 0878.160.301 |
PM GROUP BELGIUM SERVICES● Active | 0897.585.837 |
Rodolphe● Active | 0797.303.970 |
SYNAPTIX● Bankrupt | 0847.154.052 |
UNITED CONSULTING● Active | 0464.943.467 |
| 0726.823.968 | |
XPAND● Active | 0674.829.691 |
Financials
Full financial information
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 27/01/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 |
| Length of the financial year | 12 months | 12 months | 12 months |
| Filing date | 08/06/2026 | 28/05/2025 | 11/06/2024 |
| General meeting | 04/06/2026 | 27/05/2025 | 06/06/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
3 filings with the NBB
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 4 active · 7 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates06/05/2026ONTSLAGEN - BENOEMINGEN
- Capital / shares24/03/2025KAPITAAL - AANDELEN
- Mandates19/09/2024ONTSLAGEN - BENOEMINGEN
- Capital / shares06/06/2024KAPITAAL - AANDELEN
- Mandates28/03/2024ONTSLAGEN - BENOEMINGEN
- Registered office22/06/2023MAATSCHAPPELIJKE ZETEL
- Mandates15/06/2023ONTSLAGEN - BENOEMINGEN
- Mandates23/03/2023DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-201,7 k €↓
- 2024Annual accounts 2024-77,9 k €↑
- 2023Annual accounts 2023-397,1 k €
- 27/01/2023IncorporationPrivate limited company